Abstract: Storage stable aqueous ophthalmic, substantially isotonic solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl) aminophenylacetic acid, and having a pH of about 7.0 to about 7.8, comprising per ml solution:(a) about 0.1 to about 5.0 mg of a pharmaceutically acceptable salt of ortho-(2,6-dichlorophenyl)aminophenylacetic acid;(b) about 0.1 to about 10 mg of a pharmaceutically acceptable salt of ethylenediamine tetraacetic acid;(c) about 0.5 to about 200 mg of a pharmaceutically acceptable solubilizer;(d) about 0.01 to about 5.0 mg of a pharmaceutically acceptable bacteriostat; and(e) the remainder water,and the use of such solutions, by topical administration to the eye of a warm blood mammal, for the control or treatment of ocular inflammation.